Biosecure Act Excluded from Defense Bill, Boosting Chinese Biotech
TL;DR Summary
Negotiators on a key US defense bill decided not to include the Biosecure Act, which would have blacklisted five Chinese-linked biotechnology firms from federally funded research and contracts. Despite earlier support from the House and a bipartisan group in the Senate, senior House Democrats objected to naming specific companies in the legislation, resulting in a win for the Chinese biotech firms.
- Biosecure Act Out of Key Defense Bill in Win for Chinese Biotech Bloomberg
- BIOSECURE Act, aimed at Chinese drug manufacturers, is dealt a major blow STAT
- WuXi Companies Surge on Slimmer Chances of US Biosecure Passage Bloomberg
- Biosecure Act left out of defense authorization bill Axios
- Article | Republicans offer deal on bill penalizing Chinese biotechs POLITICO Pro
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
31%
88 → 61 words
Want the full story? Read the original article
Read on Bloomberg